Top 10 Fast-growings companies in PCSK9 Inhibitors by Most Patent Filing In 5 Years in the world in 2018 – Discovery

Free Trial

The PCSK9 Inhibitors top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filing In 5 Years PCSK9 Inhibitors Fast-growings in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Ranking Year:

Region:

Ranking:

1	Regeneron Pharmaceuticals, Inc.	New York, United States	Monoclonal antibody,Clinical trial,Cholesterol, ...[+2]	Patent: 142
2	CymaBay Therapeutics, Inc.	California, United States	Drug,Gout,Drug development, ...[+2]	Patent: 15
3	F. Hoffmann-La Roche Ltd.	Switzerland	Medicine,Health care,Drug, ...[+2]	Patent: 11
4	Amgen, Inc.	California, United States	Health care,Biopharmaceutical,TUMOR NECROSIS FACTOR BLOCKER, ...[+2]	Patent: 10
5	Novo Nordisk A/S	Hovedstaden, Denmark	Insulin,Health care,Haemophilia, ...[+2]	Patent: 10
6	Institut de Cardiologie De Montreal	Canada		Patent: 4
7	Shenzhen Salubris Pharmaceuticals Co., Ltd.	Guangdong Sheng, China	Medicine,Cefaclor,Antithrombotic, ...[+2]	Patent: 3
8	Sanofi	Île-de-France, France	Health care,Pharmacy and Therapeutics,Drug, ...[+2]	Patent: 3
9	Pokka Corp.	Aichi, Japan	Food industry,Soft drink,Fountain, ...[+1]	Patent: 2
10	Sanofi Biotechnology SAS	IF, FR	Biotechnology	Patent: 2